ARYSTA LIFESCIENCE

A common vision towards Bioperformance® leadership

images (6).jpg

Arysta LifeScience Acquires French-Based Company Goëmar

A common vision towards Bioperformance® leadership

Arysta LifeScience Limited has announced today the acquisition of the  Goëmar group from BeCapital and Pechel Industries. Goëmar is headquartered in Saint-Malo, France,  and is a global manufacturer and supplier of biostimulation, biocontrol and innovative nutrition for  plants, including Physio ActivatorTM and Natural Defense technologies.

This acquisition builds on Arysta LifeScience’s biosolutions platform, originally developed from the GBM (Grupo Bioquímico Mexicano) acquisition in 2007, along with their biocontrol portfolio, NPP (Natural Plant Protection), with globally recognized products such as ATONIK®, BIOZYME® and CARPOVIRUSINE®.

The two companies have already been working together to cross-market their biosolutions offerings in Europe, in addition to several commercial partnerships in high-growth countries, including India and Mexico.

Goëmar brings to Arysta LifeScience over 40 years of research and technical expertise in biosolutions, with a broad portfolio of highly differentiated products, cutting-edge innovation, and an industry-leading commercial organization with complementary competencies and geographic reach.

“Arysta LifeScience’s objective is to strengthen its leadership position in biosolutions, while also maximizing the synergies with traditional crop protection solutions,” said Wayne Hewett, CEO of Arysta LifeScience. “The acquisition of Goëmar is a key pillar for Arysta LifeScience’s continued growth in the rapidly expanding biosolutions space, with an aligned vision and passion towards this market.”

“We are excited to join Arysta LifeScience and to continue to execute our vision towards Bioperformance leadership in agriculture,” added Jean-Pierre Princen, Goëmar Chief Executive Officer. “The complementary nature of the two enterprises will provide additional capabilities to continue the tremendous growth we have experienced over the recent years. In addition, the combined strength of the two portfolios in biostimulation and biocontrol establishes a leading global player in these dynamic and growing segments.”

Terms of the transaction were not disclosed.

 

comments powered by Disqus

RW1
R1
R1
R1

This edition

Issue 30
Current


Archive


Harvest_SA The Glass Remains Half-Full For Tourism Despite Dip In Business Performance https://t.co/8YPeMWcA43 https://t.co/dSrQoHWp11 6 days - reply - retweet - favorite

Harvest_SA Challenge set for macadamia nut industry to maintain profitability for farmers https://t.co/gCHNgLWKx4 https://t.co/1jayPyqXXd 12 days - reply - retweet - favorite

Harvest_SA A snapshot of the agricultural sector and its recovery from the drought https://t.co/B8KywQL7gf 12 days - reply - retweet - favorite

  • Thabang Makokoe
  • Terrence Damster
  • Masina Skhumbuzo
  • Bareng Geoffrey Mogorosi